28 results on '"Wedzicha, Jadwiga A"'
Search Results
2. Hospitalized Exacerbations of COPD: Risk Factors and Outcomes in the ECLIPSE Cohort
3. Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype
4. The Impact of Ischemic Heart Disease on Symptoms, Health Status, and Exacerbations in Patients With COPD
5. Influence of Season on Exacerbation Characteristics in Patients With COPD
6. Reported Pneumonia in Patients With COPD: Findings From the INSPIRE Study
7. Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
8. Serum IP-10 as a Biomarker of Human Rhinovirus Infection at Exacerbation of COPD
9. The CODEX Index: A Collection or Digest of Laws: A Code
10. Rapid FEV1 Decline, Early COPD, and Angiotensin-Converting Enzymes?
11. Evidence Roflumilast Reduces Severe Exacerbations?
12. Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD
13. BLOOD EOSINOPHILS AS A PREDICTIVE MARKER OF EXACERBATION RISK IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: RESULTS FROM A POOLED ANALYSIS OF 22,125 PATIENTS
14. Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
15. Relationships Among Bacteria, Upper Airway, Lower Airway, and Systemic Inflammation in COPD
16. Mechanism of Statin-Associated Mortality Reduction in COPD
17. Exacerbations*: Etiology and Pathophysiologic Mechanisms
18. COPD EXACERBATION RATE BY BASELINE COPD ASSESSMENT TEST SCORE IN THE DYNAGITO STUDY
19. The CODEX Index
20. Rapid FEV 1 Decline, Early COPD, and Angiotensin-Converting Enzymes?
21. A Novel Study Design for the Comparison Between Once-Daily QVA149 and Twice-Daily Salmeterol/Fluticasone on the Reduction of COPD Exacerbations: The FLAME Study
22. Dual Bronchodilation With Once-Daily QVA149 Reduces Exacerbations, Improves Lung Function and Health Status Versus Glycopyrronium and Tiotropium in Severe-to-Very Severe COPD Patients: The SPARK Study
23. Once-Daily QVA149 Reduces Exacerbations and Improves Health Status in Comparison With Glycopyrronium and Tiotropium in Patients With Severe-to-Very Severe COPD: The SPARK Study
24. QVA149 Improves Lung Function and Reduces Exacerbations Compared With Tiotropium in Patients With Severe-to-Very Severe COPD: The SPARK Study
25. Response
26. Exacerbations
27. Rapid FEV1 Decline, Early COPD, and Angiotensin-Converting Enzymes?
28. Rapid FEV1Decline, Early COPD, and Angiotensin-Converting Enzymes?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.